Department of Dermatology and Venereology, 34732Peking Union Medical College Hospital, Dongcheng-qu, Beijing, China He Yi Zheng, and Jun Li contributed equally.
Int J STD AIDS. 2022 May;33(6):575-583. doi: 10.1177/09564624221086471. Epub 2022 Apr 6.
Serology is the mainstay for syphilis treatment monitoring. Baseline rapid plasma reagin (RPR) titre, HIV status, and syphilis stage have been found to be associated with the time to serological response among syphilis patients. This study mainly aims to evaluate the time to serological response, and to identify factors affecting the serological outcome. Medical records of syphilis cases diagnosed in Peking Union Medical College Hospital (PUMCH) between 2008 and 2018 were retrospectively reviewed. Kaplan-Meier analysis was performed to evaluate the median time to serologic response and cumulative probability of serologic response over time according to different variables. Cox regression model was conducted to find factors associated with serological response. There were 984 patients diagnosed with primary, secondary, or latent syphilis cases and receiving injections of benzathine penicillin G (BPG) as initial treatment at the Peking Union Medical College Hospital (PUMCH) between 2008 and 2018. Finally, data on 571 patients, including 49 (8.6%) primary syphilis, 261 (45.7%) secondary syphilis, and 261 (45.7%) latent syphilis, were used for analysis. It took longer time to achieve serological response for subjects aged ≥45 years than younger individuals (89 days versus 58 days; =0.008). Males achieved serological response more quickly than females (71 days versus 83 days; = 0.011). There was a significant difference in the time to serological response according to different syphilis stages ( < 0.001), with 55 days (95% CI, 43-67 days) for primary, 57 days (95% CI, 51-63 days) for secondary, and 117 days for latent syphilis. In addition, patients with lower baseline RPR titre had longer period to achieve serological response (252 days [95% CI, 129-375 days] for RPR titre ≤1:8, 78 days [95% CI, 63-93 days] for RPR titres from 1:16 to 1:32, and 53 days [95% CI, 49-57 days] for RPR titres ≥1:64, respectively; <0.001). However, no significant difference in time to serological response to treatment was found according to HIV coinfection status. The result of multivariate Cox regression analysis showed that being older than 45 years with latent syphilis, HIV coinfection, or with baseline RPR titre ≤1:8 was associated with slow response. Among patients followed for at least 1 year or seroreverted, 128 (36.9%) had seroreverted within a year, and 219 (63.1%) still had a positive RPR after 1 year. For multiple logistical regression, being female and HIV coinfection were significantly associated with the failure of seroreversion (OR, 0.42 [95% CI, 0.26-0.68]; <0.001). This study revealed that younger age, higher initial RPR titre, early syphilis stage, and HIV-negative status were associated with faster serological cure. Female sex, individuals with HIV coinfection, and latent syphilis were significantly associated with the failure of seroreversion.
血清学是梅毒治疗监测的主要依据。快速血浆反应素(RPR)滴度、HIV 状态和梅毒分期被发现与梅毒患者的血清学反应时间有关。本研究主要旨在评估血清学反应时间,并确定影响血清学结果的因素。回顾性分析了 2008 年至 2018 年在北京协和医院(PUMCH)诊断的梅毒病例的病历。采用 Kaplan-Meier 分析评估不同变量下血清学反应的中位时间和血清学反应的累积概率。采用 Cox 回归模型寻找与血清学反应相关的因素。最终,共纳入 984 例接受苄星青霉素 G(BPG)治疗的初发性梅毒、二期梅毒和潜伏性梅毒患者。共有 571 例患者(49 例初发性梅毒[8.6%]、261 例二期梅毒[45.7%]和 261 例潜伏性梅毒[45.7%])纳入分析。≥45 岁的患者血清学反应时间长于年龄<45 岁的患者(89 天比 58 天;=0.008)。男性血清学反应时间快于女性(71 天比 83 天;=0.011)。不同梅毒分期的血清学反应时间有显著差异(<0.001),初发性梅毒为 55 天(95%CI,43-67 天),二期梅毒为 57 天(95%CI,51-63 天),潜伏性梅毒为 117 天。此外,基线 RPR 滴度较低的患者达到血清学反应的时间较长(RPR 滴度≤1:8 的患者为 252 天(95%CI,129-375 天),RPR 滴度为 1:16 至 1:32 的患者为 78 天(95%CI,63-93 天),RPR 滴度≥1:64 的患者为 53 天(95%CI,49-57 天);<0.001)。然而,根据 HIV 合并感染状况,血清学反应时间无显著差异。多变量 Cox 回归分析结果表明,年龄>45 岁的潜伏性梅毒、HIV 合并感染或基线 RPR 滴度≤1:8 与反应缓慢有关。在随访至少 1 年或血清学恢复的患者中,128 例(36.9%)在 1 年内血清学恢复,1 年后仍有 219 例(63.1%)RPR 阳性。多因素逻辑回归分析显示,女性和 HIV 合并感染与血清学恢复失败显著相关(OR,0.42[95%CI,0.26-0.68];<0.001)。本研究表明,年龄较小、初始 RPR 滴度较高、早期梅毒阶段和 HIV 阴性状态与更快的血清学治愈有关。女性、HIV 合并感染和潜伏性梅毒与血清学恢复失败显著相关。